Advisors Asset Management’s CureVac CVAC Stock Holding History

Advisors Asset Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-907	Closed	-$83K	–	1426
2021 Q1	$83K	Buy	+907	New	+$88K	﹤0.01%	1357

Other funds holding CVAC

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisors Asset Management's CVAC Position: Q2 2021 in Review

Advisors Asset Management sold out of CureVac (CVAC) in Q2 2021, closing a stake of 907 shares — an estimated $83K sold.

Advisors Asset Management first reported a position in CVAC in Q1 2021 and held it in 1 quarter. The position peaked at $83K in Q1 2021. 109 funds tracked by Wall St. Rank hold CVAC as of Q2 2021.

Advisors Asset Management reported no remaining CureVac position as of Q2 2021 after selling out during the quarter.
Advisors Asset Management sold 907 CureVac shares in Q2 2021, an estimated $83K.
Advisors Asset Management first reported a position in CureVac in Q1 2021 and held it in 1 quarter.
Advisors Asset Management's CureVac position peaked at $83K in Q1 2021.
109 funds tracked by Wall St. Rank held CureVac as of Q2 2021.

Based on Advisors Asset Management's 13F filing for Q2 2021, filed 30 Jul 2021.